Table 6 of
Ban, Mol Vis 2011; 17:2533-2543.
Table 6. Comparison of meibomian glands assessed by in vivo laser confocal microscopy, MG expressibility, meibography and lid margin abnormality between the DE/cGVHD group without systemic cGVHD and non-DE/non-cGVHD group.
Examinations |
DE/cGVHD group without systemic cGVHD (7 eyes, 4 cases) |
non-DE/non-cGVHD group (16 eyes, 8 cases) |
p-value |
|---|---|---|---|
| MGAUD (glands/mm2) | 85.3±32.3 | 88.8±26.6 | 0.8021 |
| MGALD (μm) | 63.0±14.2 | 60.4±11.8 | 0.65 |
| MGASD (μm) | 27.6±12.0 | 26.6±6.03 | 0.7888 |
| Fibrosis (grade) | 0.71±0.59 | 0.06±0.25 | 0.0016‡ |
| MG expressibility (points) | 2.20±1.10 | 0.75±0.93 | 0.0189‡ |
| Meibography (grade) | 1.14±0.69 | 0.50±0.52 | 0.0399‡ |
| Lid margin (grade) | 2.0±1.41 | 0.38±0.72 | 0.0019‡ |